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In-situ detection of psychoactive 
substances in a custodial setting 
•  HM Chief Inspector of Prisons 
for England & Wales, Annual 
Report 2013–14. 
•  Identified as an emerging 
threat – due to lack of 
methods for detection. 
 
•  UK Psychoactive Subs Act 
(May 2016). 
•  UK Misuse of Drugs Act (Dec 
2016). 
•   Mental health impact. 
•  Self-harm, violence & suicide. 
 
•  Homeless/Rough Sleeping 
Community (MANDRAKE). 
Synthetic Cannabinoids (SCRAs, Spice, Mamba) 
60 – 90% of UK male prison 





Secure, traceable and 
compliant protocol. 
Chain of custody. Forms of Spice	
CUSTODIAL SETTING OUTCOMES? 
1MANchester DRug Analysis & Knowledge Exchange. 
MR Scanner (in GMP)	
HMP Holme House 
•  Category C (Male) 
•  Capacity: 1210 
•  Improve Safety & Security. 
•  Physical – Technology. 
•  Personal – Interventions. 
•  Procedural – Adjudications. 
Project Orpheus (study parameters) 
 
•  3 months (April – July 2018). 
•  Training & implementation by non-technical staff. 
•  Screening of suspected contraband (interception analysis). 
•  Forensic cross-validation by MANDRAKE @ Manchester Metropolitan Uni. 






















2All samples cross-validated/confirmed by GC-MS. 
















•  Data gained from study potentially indicates multiple sources and 
supply streams. 
Outcomes of Study 
•  Identification and disruption of routes of supply. 
 
•  Reduction in specific supply methods and volume of contraband. 
•  Reduction in frequency of medical intervention. 
•  Increased perception of safety by staff and prisoners.  
•  Inform on prevalence of drugs within a custodial setting. 
•  Targeted harm reduction based on findings. 
 
•  Better understanding of the chemicals  being trafficked and consumed 
in the prison. 
•  Increased intelligence-gathering and best practice-sharing. 
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